Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-05-08
Mandadi Tilak Files CVS Health (CVS) Form 4 - May 08, 2026
Mandadi Tilak sold 69.6K CVS shares worth $6.2M in this Form 4 filing, reported to the SEC on 2026-05-08.
- Insider
- Mandadi Tilak
- Issuer
- CVS Health Corporation CVS · NYSE
- Filed
- Period
- 2026-05-08
- Accession
- 0000064803-26-000056
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Mandadi Tilak | 2026-05-08 | Sell | 69.6K | $89.58 | $6.2M | Direct |
| Net change | −69.6K | −$6.2M | ||||
About CVS Health Corporation
CVS Health Corporation is a leading health services company in the United States, offering a comprehensive range of services aimed at improving healthcare accessibility and convenience. Primarily known for its extensive network of pharmacies, CVS Health operates thousands of retail locations nationwide. These outlets provide prescription medications, over-the-counter drugs, health and wellness products, and immunization services. Beyond retail, CVS Health plays a significant role in the healthcare sector through its pharmacy benefit management division, Caremark, which administers prescription drug plans for insurers and employers. Additionally, the company owns Aetna, a major health insurance provider, aligning its services across retail, pharmacy benefits, and insurance solutions to deliver integrated healthcare experiences. With its broad reach and diverse healthcare offerings, CVS Health Corporation holds a critical place in the healthcare market, continuously working to streamline and enhance the delivery of medical services across the country.
Track CVS insider activity
Get alerted when CVS Health Corporation executives buy or sell their shares.